Good news from Russia on corona virus vaccine: Sputnik-V is also 95% effective, free to Russian people and 10 dollar to other countries. This vaccine will be available in less than

The Russian-made Corona vaccine has proven to be 95% effective in fighting corona during the Sputnik V trial. This is revealed in the second preliminary analysis of the clinical trial. 28 days after the first dose, this vaccine showed 91.4% efficacy. 42 days after the first dose, it increased to 95%.

The Gamalia National Research Center for Epidemiology and Microbiology, which makes the vaccine, has claimed this. Two doses of the vaccine were given to 18,794 other patients besides 39 infected.

The price of this vaccine has also come out on Tuesday. This will be given free to the people of Russia. For other countries of the world, its price will be less than 10 dollars. Kirill Dimitriyev, head of the Russian Director Investment Fund (RDIF), which oversees the production and promotion of the vaccine abroad, says that the potential price of Sputnik V has been significantly reduced compared to other vaccines.

Much cheaper than other vaccines

According to information given by RDIF, two doses of this vaccine will have to be taken. This price is two to three times lower than other vaccines made by mRNA technology. RDIF has tied up with partners from other countries to make vaccines for more than 500 millions in 2021.

Storage possible in 2 to 8 ° C.

RDIF and its partners are preparing a dry dose of the vaccine. This vaccine will also be safe in 2 to 8 degree Celsius temperature. Due to this, its distribution in the international market will be much easier. It will also be easy to transport it to remote places. These can also include countries with warmer temperatures.

First delivery will be in January

The first delivery of this vaccine will be done in January next year. At the same time, other countries who have requested for this, will get their first batch from the beginning of March 2021.

So far no side effects

40,000 tens of volunteers are participating in the vaccine's third phase trial. The first dose was awarded to 22000 tens of volunteers. More than 19000 tens of people have been given both first and second doses. No threat has been revealed in them so far. Monitoring of volunteers is still going on.

This vaccine is more than 90% effective

Oxford AstraZeneca claims that its vaccine Kovyshield can remain up to 90% effective. This vaccine has been 70% effective in large scale human trials.

American pharmaceutical companies Pfizer and Moderna also claimed to have more than 90 percent of their vaccine effective.

Will cost so much

According to Pfizer, one dose of his vaccine would cost $ 19.50.

Moderna will cost 25 to 37 dollars.

Their two doses will cost $ 39 and $ 50 to 74.